Drugs · Brain health technique

SGLT2 Inhibitors

Evidence grade: Context Dependent

Illustration for SGLT2 Inhibitors

Oral medications that reduce blood glucose by promoting renal glucose excretion and improving vascular and metabolic health. Includes empagliflozin (Jardiance®), dapagliflozin (Farxiga®), and canagliflozin (Invokana®).

Practice
Drugs
Principle
Treatment
Tactic
Metabolic & Vascular Optimization Drugs
Evidence grade
Context Dependent
Strength of evidence
Medium

How to practice SGLT2 Inhibitors

Used for type 2 diabetes, heart failure, or kidney disease. Typical dosing: once-daily tablet. Monitor hydration, kidney function, and infection risk. Avoid in severe renal impairment or frequent dehydration. Combine with exercise and balanced diet for maximum benefit. Neuroprotective effects remain under investigation.

The evidence behind SGLT2 Inhibitors

In people with type 2 diabetes, clinical trials show these drugs lower the risk of heart failure, kidney disease, and death from heart and blood vessel disease. Early studies also suggest these drugs improve endothelial function.

Impact on brain health

Some studies suggest these drugs also improve blood flow to the brain. These drugs may protect memory and thinking by improving how the body switches between fuels and uses ketones. Long-term data on these effects are still pending.

Reviewed by BetterBrain's clinical advisors · Updated November 2026 · Our science

Pair this with other habits from the same practice.

  • Evidence grade: Context Dependent

    Anti-Amyloid Monoclonal Antibodies

    FDA-approved biologic drugs that target beta-amyloid plaques to slow Alzheimer’s progression, including lecanemab (Leqembi®), donanemab (Kisunla™).

    Medium effort

  • Evidence grade: Context Dependent

    Antihypertensives

    Medications that lower blood pressure to protect vascular and brain health, including ACE inhibitors (lisinopril, enalapril), ARBs (losartan, valsartan), calcium channel blockers…

    Low effort · High cost

  • Evidence grade: Context Dependent

    GLP-1 Receptor Agonists

    A class of injectable or oral medications that mimic the hormone glucagon-like peptide-1 (GLP-1) to improve insulin sensitivity, suppress appetite, and reduce inflammation.

See all 20 drugs techniques →

Take control of your brain health

BetterBrain gives you a personalized protocol of techniques like these, backed by science and tailored to you.

How BetterBrain worksSee pricing